Blood Glucose Monitoring for Patients on Ryzodeg (Insulin Degludec/Aspart)
Patients on Ryzodeg should monitor blood glucose before meals and snacks, at bedtime, occasionally postprandially, when suspecting hypoglycemia, after treating low blood glucose until normoglycemic, and before critical tasks like driving—typically requiring 6-10 tests daily. 1, 2, 3
Monitoring Frequency Based on Insulin Regimen
Since Ryzodeg is a combination insulin product containing both basal (degludec) and rapid-acting (aspart) components, it functions as an intensive insulin regimen requiring comprehensive monitoring:
Daily Testing Schedule
- Before each meal and snack: Essential for determining prandial insulin coverage needs 1, 2, 4
- At bedtime: Critical for assessing overnight glycemic control and preventing nocturnal hypoglycemia 1, 3
- Occasionally postprandially (1-2 hours after meals): Particularly important when A1C goals aren't met despite adequate fasting glucose, as postprandial hyperglycemia may be the primary issue 5, 6
- Before exercise: To prevent exercise-induced hypoglycemia 1, 2
- When suspecting hypoglycemia: Immediate testing required for any symptoms 1, 3
- After treating hypoglycemia: Continue monitoring until normoglycemic 1, 2, 4
- Before critical tasks: Especially driving or operating machinery 1, 2, 3
Special Considerations for Ryzodeg
The timing of Ryzodeg administration relative to meals directly impacts monitoring strategy. When dosed once daily with the largest meal, fasting glucose measurements guide basal component adequacy, while pre-meal and postprandial readings at the injection meal assess the aspart component 7, 8. If intensified to twice-daily dosing, monitoring should occur before both injection meals 7.
Hypoglycemia Monitoring Priority
Nocturnal hypoglycemia risk is significantly lower with Ryzodeg compared to other insulin regimens (75% lower than insulin glargine), but overall hypoglycemia rates are higher, making frequent monitoring essential. 8 The diurnal hypoglycemia risk is particularly elevated when Ryzodeg is dosed at breakfast rather than with the main meal 8.
Critical Hypoglycemia Checkpoints
- Middle of the night testing: Indicated if any symptoms of nocturnal hypoglycemia occur 9
- Fasting measurements: Daily assessment to detect overnight or early morning hypoglycemia 6
- Pre-exercise testing: Mandatory before physical activity 1, 2
Continuous Glucose Monitoring Alternative
For patients struggling with frequent fingerstick testing or experiencing hypoglycemia unawareness, continuous glucose monitoring (CGM) can be considered as an adjunct or alternative to self-monitoring blood glucose 1, 2, 3. CGM requires calibration with fingerstick measurements and treatment decisions should still be based on confirmatory fingerstick readings 1, 4.
A1C Monitoring Schedule
Beyond daily glucose monitoring:
- Quarterly A1C testing: Required when therapy has changed or glycemic goals aren't being met 5, 10, 11
- Every 6 months: Acceptable for patients with stable glycemic control meeting treatment goals 5, 10, 11
Common Pitfalls to Avoid
Do not rely solely on fasting glucose when using Ryzodeg. The aspart component specifically targets postprandial excursions, and inadequate postprandial monitoring will miss a major component of glycemic control 5, 6.
Avoid sliding-scale-only approaches without basal monitoring. Patients must understand that the degludec component requires fasting glucose assessment for dose titration, while the aspart component needs pre-meal and postprandial evaluation 7, 12.
Ensure patients receive ongoing instruction and regular evaluation of monitoring technique, results, and ability to use data for therapy adjustments. 1, 2, 3 Simply prescribing frequent monitoring without education on data interpretation and action plans leads to poor outcomes.